Two former senior generic pharmaceutical executives have been charged with conspiring to fix prices, rig bids, and allocate customers for certain generic drugs, the Justice Department announced today.
Jeffrey Glazer, the former CEO of a generic pharmaceutical company, and Jason Malek, the former president of the same company, were charged with two-count felony charges in the United States District Court for the Eastern District of Pennsylvania in Philadelphia.
According to the Informations, Glazer and Malek conspired to fix prices, rig bids, and allocate customers for an antibiotic, doxycycline hyclate, from as early as April 2013 until at least December 2015.
The Informations also allege that Glazer and Malek conspired to fix prices and allocate customers for glyburide, a medicine used to treat diabetes, from as early as April 2014 until at least December 2015.
“Millions of Americans rely on prescription medications to treat acute and chronic health conditions. By entering into unlawful agreements to fix prices and allocate customers, these two executives sought to enrich themselves at the expense of sick and vulnerable individuals who rely upon access to generic pharmaceuticals as a more affordable alternative to brand-name medicines,” said Deputy Assistant Attorney General Brent Snyder of the Justice Department’s Antitrust Division.
“Conspiring to fix prices on widely-used generic medications skews the market, flouts common decency – and very clearly breaks the law,” said Special Agent in Charge Michael Harpster of the FBI’s Philadelphia Division.
Tonight’s charges are the result of an ongoing federal antitrust investigation into price fixing, bid rigging, and other anticompetitive conduct in the generic pharmaceutical industry, which is being conducted by the Antitrust Division’s Washington Criminal I Section with the assistance of the FBI’s Philadelphia Division, the FBI headquarters’ International Corruption Unit, the United States Postal Service Office of Inspector General, and the U.S. Attorney’s Office for the Eastern District of Pennsylvania.
If you have information on market allocation, price fixing, bid rigging, and other anticompetitive conduct related to the generic pharmaceutical industry, contact the Antitrust Division’s Citizen Complaint Center at 1-888-647-3258, visit www.justice.gov/atr/contact/newcase.html or call the FBI’s Philadelphia Division at 215-418-4000.
Jeffrey Glazer Information: Jeffrey Glazer, the former CEO of a generic pharmaceutical company, has been charged with two-count felony charges in the United States District Court for the Eastern District of Pennsylvania in Philadelphia.
Jason Malek Information: Jason Malek, the former president of a generic pharmaceutical company, has been charged with two-count felony charges in the United States District Court for the Eastern District of Pennsylvania in Philadelphia.
Related Federal Cases
- Canadian Firm, 3 Execs Accused in $4M Foreign Drug Scheme · Washington
- Jury Convicts Leaford Cameron in Nationwide Law Fraud Scheme · Pennsylvania
- Romanian National Pleads Guilty in ATM Skimming Scheme · Washington
- Jennifer Hess, 50, Pleads Guilty to Opioid Fraud Scheme · Washington
- Zedan RaShwan Charged in $ Drug Fraud Scheme · Washington
Key Facts
- State: Federal
- Category: Drug Trafficking|Fraud & Financial Crimes|Violent Crime|Cybercrime|Public Corruption|Weapons|Human Trafficking|White Collar Crime|Organized Crime
- Source: DOJ Press Release â†â€â€
ðŸâ€Â’ Get the grimiest stories delivered weekly. Subscribe free →
